Key Board Member Resigns from Jupiter Neurosciences Amidst Financial Distress
Summary
Allison W. Brady has resigned from Jupiter Neurosciences' Board of Directors and its Audit and Compensation Committees, effective June 17, 2026. This departure adds to governance concerns for a micro-cap company already facing severe financial distress, including 'going concern' warnings and Nasdaq delisting threats. While the company stated no disagreement, the loss of a board member from key oversight committees creates further instability. The board seat will remain vacant until the annual meeting on July 22, 2026, where a reverse stock split is also up for shareholder approval.
At the time of this announcement, JUNS was trading at $0.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $0.17 to $3.33. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.